Similar Articles
511 Prospect of lenvatinib for unresectable hepatocellular carcinoma in the new era of systemic chemotherapy
512 Anatomic resection improved the long-term outcome of hepatocellular carcinoma patients with microvascular invasion: A prospective cohort study
513 Critical biomarkers of hepatocellular carcinoma in body fluids and gut microbiota
514 Hepatocellular carcinoma: Understanding molecular mechanisms for defining potential clinical modalities
515 Tumor characteristics of hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C: Comparative analysis with antiviral therapy-naive patients
516 Circulating microRNA 9-3p and serum endocan as potential biomarkers for hepatitis C virus-related hepatocellular carcinoma
517 Hepatocellular carcinoma locoregional therapies: Outcomes and future horizons
518 Survivin-positive circulating tumor cells as a marker for metastasis of hepatocellular carcinoma
519 Emerging role of long noncoding RNAs in recurrent hepatocellular carcinoma
520 Radiomics in hepatocellular carcinoma: A state-of-the-art review
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA